Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (691-700 of 743) with videos related to

Pageof 75
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
JAMA Network Open|April 21, 2022
Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive ImpairmentYan Hu, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisJoseph Bradley, Daniel Western, Ciyang Wang, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseasesYing Xu, Marisa N Denkinger, Menghan Liu, et al.
Brain : a Journal of Neurology|June 27, 2018
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APPFrances K Wiseman, Laura J Pulford, Chris Barkus, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 23, 2015
Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort studyYuk Yee Leung, Jon B Toledo, Alexey Nefedov, et al.
Neuron|October 1, 2024
Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy modelGillian K Carling, Li Fan, Nessa R Foxe, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Pageof 75

Showing results (691-700 of 743) with videos related to

Sort By:
Pageof 75
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
JAMA Network Open|April 21, 2022
Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive ImpairmentYan Hu, Kristopher M Kirmess, Matthew R Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisJoseph Bradley, Daniel Western, Ciyang Wang, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseasesYing Xu, Marisa N Denkinger, Menghan Liu, et al.
Brain : a Journal of Neurology|June 27, 2018
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APPFrances K Wiseman, Laura J Pulford, Chris Barkus, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 23, 2015
Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort studyYuk Yee Leung, Jon B Toledo, Alexey Nefedov, et al.
Neuron|October 1, 2024
Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy modelGillian K Carling, Li Fan, Nessa R Foxe, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Pageof 75